TEVETEN PLUS 600 MG — DIN 02253631
EPROSARTAN (EPROSARTAN MESYLATE) : 600 MG HYDROCHLOROTHIAZIDE : 12.5 MG · BGP PHARMA ULC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is TEVETEN PLUS?
TEVETEN PLUS 600 MG contains EPROSARTAN (EPROSARTAN MESYLATE) : 600 MG HYDROCHLOROTHIAZIDE : 12.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02253631, held by BGP PHARMA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-Sep-2023. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is TEVETEN PLUS used for?
TEVETEN® PLUS (eprosartan mesylate and hydrochlorothiazide) is indicated for the treatment of mild to moderate essential hypertension in patients for whom combination therapy with both eprosartan and hydrochlorothiazide is appropriate. TEVETEN® PLUS is not indicated for initial therapy.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Eprosartan And Diuretics cost around the world?
Eprosartan And Diuretics is listed on 5 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Belgium publishes a public; South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 2 | 6 | AUD███.██ |
| Spain | PVP con IVA (public price) | 3 | 3 | EUR███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
| South Africa | single exit price | 2 | 2 | ZAR███.██ |
| Belgium | public | 1 | 1 | EUR███.██ |
15 pack listings across 11 brand entries and 5 price bases, refreshed 08 Sep 2026. Ranges span every Eprosartan And Diuretics pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 600 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | blister packs of 28 tablets |
| Storage | null |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Eprosartan And Diuretics |
|---|---|
| ATC code | C09DA02 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02253631 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2253631 |
| Brand name | TEVETEN PLUS |
| Generic / active ingredient | EPROSARTAN (EPROSARTAN MESYLATE) : 600 MG HYDROCHLOROTHIAZIDE : 12.5 MG |
| Market authorization holder | BGP PHARMA ULC |
| Health Canada schedule | Prescription |
| ATC code | C09DA02 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09DA |
| Current status | CANCELLED POST MARKET |
| Status date | 18-Sep-2023 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Individualized dosage; not for initial therapy. Once stabilized on components, 1 tablet daily. Take with or without food at the same time each day.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ingredients or sulfonamides; pregnancy/nursing; anuria; severe renal/hepatic impairment; cholestasis; renovascular disease; refractory electrolyte imbalances; gout; galactose intolerance.
Warnings and precautions
Fetal toxicity; hypotension; dual blockade of RAAS; electrolyte imbalance; non-melanoma skin cancer; acute respiratory distress syndrome; acute myopia/glaucoma.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
2 · Same class — other molecules in ATC C09DA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Valsartan And Diuretics | APO-VALSARTAN/HCTZ · AURO-VALSARTAN HCT · AVA-VALSARTAN HCT · DIOVAN-HCT · +8 more | 63 | 32 | Yes |
| Candersartan And Diuretics | ACCEL-CANDESARTAN/HCTZ · ACT CANDESARTAN/HCT · AG-CANDESARTAN HCT · APO-CANDESARTAN/HCTZ · +16 more | 49 | 22 | Yes |
| Telmisartan And Diuretics | ACH-TELMISARTAN HCTZ · ACT TELMISARTAN/HCT · AG TELMISARTAN-HCT · ALEMBIC-TELMISARTAN/HCTZ · +17 more | 42 | 22 | Yes |
| Losartan And Diuretics | ACT LOSARTAN/HCT · AG-LOSARTAN HCTZ · APO-LOSARTAN/HCTZ · AURO-LOSARTAN HCT · +19 more | 53 | 21 | Yes |
| Olmesartan Medoxomil And Diuretics | ACH-OLMESARTAN HCTZ · AG-OLMESARTAN HCTZ · APO-OLMESARTAN/HCTZ · AURO-OLMESARTAN HCTZ · +11 more | 45 | 21 | Yes |
| Irbesartan And Diuretics | ACT IRBESARTAN/HCT · AG-IRBESARTAN HCTZ · APO-IRBESARTAN/HCTZ · AURO-IRBESARTAN HCT · +19 more | 67 | 17 | Yes |
| Azilsartant Medoximil And Diuretics | EDARBYCLOR | 3 | 2 | Yes |
| Eprosartan And Diuretics | TEVETEN PLUS | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C09D
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C09DB | Telmisartan And Amlodipine | 12 | 8 |
| C09DX | Valsartan And Sacubitril | 6 | 6 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is TEVETEN PLUS called?
The same molecule, Eprosartan And Diuretics, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Teveten | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.